Printer Friendly

Eiken Chemical Transfers Manufacturing and Marketing Rights of Two Contrast Agents to Guerbet Japan.

Tokyo, Japan, Oct 17, 2005 - (JCNN) - Eiken Chemical announced on October 17 that it has transferred the manufacturing and marketing rights to its two contrast agents, Hexabrix 320 for urography and angiography and Magnescope Syringe for MRI, to Guerbet Japan, a Japanese subsidiary of French contrast agent manufacturer Guerbet AG.

With this move, Eiken Chemical aims to concentrate its management resources on the clinical diagnostic business while Guerbet will seek to increase its presence in Japan.

In line with Eiken Chemical's announcement, Tanabe Seiyaku, the current distributor of Hexabrix 320 and Magnescoep, announced on the same day that it has reached an agreement with Terumo, whereby it will transfer the sales of the two products to Terumo as of January 1, 2006.

Source: JCN http://www.japancorp.net

Copyright [c] 2005 Japan Corporate News Network. All rights reserved.
COPYRIGHT 2005 Japan Corporate News Network K.K.
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2005, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

Article Details
Printer friendly Cite/link Email Feedback
Publication:JCNN News Summaries
Date:Oct 18, 2005
Words:138
Previous Article:Ajinomoto Develops World's First Health Check Method Based on Blood Amino Acid Concentrations.
Next Article:Terumo Acquires Exclusive Sales Rights for Three Contrast Agents from Guerbet AG.


Related Articles
Terumo Acquires Exclusive Sales Rights for Three Contrast Agents from Guerbet AG.
Eiken Chemical to Release LAMP-based Listeria Monocyogenes Reagent Test Kit.
Alfresa Pharma to Become Distributor of Anafranil Antidepressant.
Sanofi-aventis Japan Acquires Production and Sales Rights of Ancaron Antiarrhythmic Agent from Taisho Pharmaceutical.
Sumitomo Chemical Files Suit Against Pfizer for Amlodipine Besilate.
Toyama Chemical, NIDEK Receive Manufacturing Approval for New-quinolone Ophthalmic Solutions.
Eiken Chemical to Release LAMP-based Camplybacter Reagent Test Kit.
Astellas and Toyama Chemical Announce Basic Licensing Agreement on Domestic Marketing and Joint Development of Quinolone Antibiotic T-3811.
Eiken to Launch New Subsidiary and Factory in China.

Terms of use | Privacy policy | Copyright © 2021 Farlex, Inc. | Feedback | For webmasters